Clinical Trials Directory

Trials / Sponsors / K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Industry · 7 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
TerminatedZN-c3 in Adult Participants With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Phase 12023-02-27
RecruitingA Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube o
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase 22022-02-17
CompletedA Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
Ovarian Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Carcinoma
Phase 1 / Phase 22022-01-27
CompletedA Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma
Osteosarcoma
Phase 12021-08-01
CompletedA Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma
Uterine Serous Carcinoma
Phase 22021-07-28
RecruitingA Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 12020-10-26
CompletedA Study of Azenosertib (ZN-c3) in Participants With Solid Tumors
Solid Tumor
Phase 12019-11-01